
Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH
- Achterstrasse 30
- D-28359 Bremen
- Tel: +49 (0)421 218-56750
- Fax: +49 (0)421 218-56941
Institute director
Prof. Dr. Iris Pigeot
Monitoring the safety of high potency opioids in patients with and without alcohol related diagnoses
Description
- For some drugs alcohol consumption can lead to an increased incidence of adverse drug reactions. This study will investigate the prevalence of excessive alcohol consumption (measured through the proxy of alohol-related diagnoses) in users of the drug group that is being investigated. Further, the safety of the group of drugs in patients with and without alcohol related disorders will be investigated.
Due to a confidentiality agreement full information about this project cannot be made available
Funding period
- Begin: January 2008
End: June 2013
Contact
- Kathrin Jobski
Sponsor
- Pharmazeutische Industrie
Selected project-related publications
Articles with peer-review
- Jobski, Kathrin; Schmid, Ulrike; Behr, Sigrid; Andersohn, Frank; Garbe, Edeltraut (2012). 3-year prevalence of alcohol-related disorders in German patients treated with high-potency opioids. Pharmacoepidemiology and Drug Safety, 21 (10):1125 - 1129. http://dx.doi.org/10.1002/pds.3268.
Posters at scientific meetings/conferences
- Jobski, Kathrin; Schmid, Ulrike; Behr, Sigrid; Andersohn, Frank; Garbe, Edeltraut (2010). Prevalence of alcohol related disorders in German patients treated with high-potency opioids. 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 19.-22. August 2010, Brighton, England